Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance

Transplantation. 2014 Jul 27;98(2):131-8. doi: 10.1097/TP.0000000000000204.

Abstract

Background: We have previously demonstrated that tolerance to a vascularized composite allograft (VCA) can be achieved after the establishment of mixed chimerism. We test the hypothesis that tolerance to a VCA in our dog leukocyte antigen-matched canine model is not dependent on the previous establishment of mixed chimerism and can be induced coincident with hematopoietic cell transplantation (HCT).

Methods: Eight dog leukocyte antigen-matched, minor antigen mismatched dogs received 200 cGy of radiation and a VCA transplant. Four dogs received donor bone marrow at the time of VCA transplantation (group 1), whereas a second group of four dogs did not (group 2). All recipients received a limited course of postgrafting immunosuppression. All dogs that received HCT and VCA were given donor, third-party, and autologous skin grafts.

Results: All group 1 recipients were tolerant to their VCA (>62 weeks). Three of the four dogs in group 2 rejected their VCA transplants after the cessation of immunosuppression. Biopsies obtained from the muscle and skin of VCA from group 1 showed few infiltrating cells compared with extensive infiltrates in biopsies of VCA from group 2. Compared with autologous skin and muscle, elevated levels of CD3+ FoxP3+ T-regulatory cells were found in the skin and muscle obtained from the VCA of HCT recipients. All group 1 animals were tolerant to their donor skin graft and promptly rejected the third-party skin grafts.

Conclusion: These data demonstrated that donor-specific tolerance to all components of the VCA can be established through simultaneous nonmyeloablative allogeneic HCT and VCA transplantation protocol.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • CD3 Complex / metabolism
  • Composite Tissue Allografts
  • Cytokines / metabolism
  • Dogs
  • Forkhead Transcription Factors / metabolism
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Graft Survival* / drug effects
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Histocompatibility
  • Histocompatibility Antigens / immunology
  • Immunosuppressive Agents / pharmacology
  • Myeloablative Agonists / pharmacology
  • Skin Transplantation* / adverse effects
  • T-Lymphocytes, Regulatory / immunology
  • Time Factors
  • Transplantation Chimera
  • Transplantation Tolerance* / drug effects
  • Vascularized Composite Allotransplantation* / adverse effects

Substances

  • Biomarkers
  • CD3 Complex
  • Cytokines
  • Forkhead Transcription Factors
  • Histocompatibility Antigens
  • Immunosuppressive Agents
  • Myeloablative Agonists